Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence, associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based imaging techniques have dramatically improved the ability of ultrasound to detect and quantify hepatic steatosis. These newer ultrasound techniques possess many inherent advantages similar to conventional ultrasound such as universal availability, real-time capability, and relatively low cost along with quantitative rather than a qualitative assessment of liver fat. In addition, quantitative ultrasound-based imaging techniques are less operator dependent than traditional ultrasound. Here we review several different emerging quantitative ultrasound-based approaches used for detection and quantification of hepatic steatosis in patients at risk for nonalcoholic fatty liver disease. We also briefly summarize other clinically available imaging modalities for evaluating hepatic steatosis such as MRI, CT, and serum analysis.

[1]  T. Yamanaka,et al.  Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. , 2016, Gastroenterology.

[2]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[3]  E. Lawitz,et al.  The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study , 2005, BMC gastroenterology.

[4]  Yoosoo Chang,et al.  Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population , 2013, The American Journal of Gastroenterology.

[5]  Alex A. T. Bui,et al.  Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content , 2018, Theranostics.

[6]  Marco Salvatore,et al.  Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.

[7]  Ronald H. Silverman,et al.  Ultrasonic spectrum analysis for tissue assays and therapy evaluation , 1997, Int. J. Imaging Syst. Technol..

[8]  Paulo R. S. Mendonça,et al.  Contrast-Independent Liver-Fat Quantification from Spectral CT Exams , 2013, MICCAI.

[9]  S. Curley,et al.  Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.

[10]  Jaap Stoker,et al.  MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis. , 2017, Radiology.

[11]  Hsiang-Yang Ma,et al.  Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis , 2016, Scientific Reports.

[12]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[13]  D. Brenner,et al.  Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease , 2017 .

[14]  W. O’Brien,et al.  Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[15]  Chien-Cheng Chang,et al.  Using ultrasound Nakagami imaging to assess liver fibrosis in rats. , 2012, Ultrasonics.

[16]  R. Stolk,et al.  Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy , 2009, Obesity.

[17]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[18]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.

[19]  A. Feldstein,et al.  Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.

[20]  M. Reiser,et al.  Material differentiation by dual energy CT: initial experience , 2007, European Radiology.

[21]  M. Manns,et al.  Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. , 2018, Journal of hepatology.

[22]  K. Clément,et al.  Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data , 2012, PloS one.

[23]  Hiroyuki Hachiya,et al.  A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. , 2006, Journal of hepatology.

[24]  A. Gamst,et al.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.

[25]  Shuicai Wu,et al.  Hepatic Steatosis Assessment Using Quantitative Ultrasound Parametric Imaging Based on Backscatter Envelope Statistics , 2019, Applied Sciences.

[26]  H. Toyoda,et al.  Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction. , 2019, AJR. American journal of roentgenology.

[27]  C. Lackner Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective , 2011, Expert review of gastroenterology & hepatology.

[28]  Kouichi Itoh,et al.  A new method for measuring the speed of sound in rat liver ex vivo using an ultrasound system: correlation of sound speed with fat deposition. , 2014, Ultrasound in medicine & biology.

[29]  V. Wong,et al.  Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population , 2017, United European gastroenterology journal.

[30]  Hiroyuki Hachiya,et al.  B-mode ultrasound with algorithm based on statistical analysis of signals: evaluation of liver fibrosis in patients with chronic hepatitis C. , 2009, AJR. American journal of roentgenology.

[31]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[32]  R. Jeffrey,et al.  Intra-Individual Comparison between 2-D Shear Wave Elastography (GE System) and Virtual Touch Tissue Quantification (Siemens System) in Grading Liver Fibrosis. , 2017, Ultrasound in medicine & biology.

[33]  C. Sirlin,et al.  Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[34]  Nik Raihan Nik Mustapha,et al.  Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Journal of gastroenterology and hepatology.

[35]  John M. Reid,et al.  Analysis and measurement of ultrasound backscattering from an ensemble of scatterers excited by sine‐wave bursts , 1973 .

[36]  C. R. Hill,et al.  Acoustic properties of normal and cancerous human liver-II. Dependence of tissue structure. , 1981, Ultrasound in medicine & biology.

[37]  Kouichi Itoh,et al.  A New Method for Attenuation Coefficient Measurement in the Liver , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[38]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[39]  Y. Takikawa,et al.  Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. , 2012, World journal of gastroenterology.

[40]  L. Katsnelson,et al.  Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.

[41]  Thomas Deffieux,et al.  Robust sound speed estimation for ultrasound-based hepatic steatosis assessment , 2017, Physics in medicine and biology.

[42]  Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. , 2017, Medical engineering & physics.

[43]  K. Itoh,et al.  Studies on frequency‐dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral‐shift zero‐crossing method , 1988, Journal of clinical ultrasound : JCU.

[44]  Haim Azhari,et al.  Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. , 2004, Ultrasound in medicine & biology.

[45]  Chih-Kuang Yeh,et al.  Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease , 2016, Scientific Reports.

[46]  H. Garg,et al.  Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. , 2018, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[47]  Rohit Loomba,et al.  Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.

[48]  W. O’Brien,et al.  Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD , 2019, European Radiology.

[49]  M. Chammas,et al.  Ultrasound Elastography: Review of Techniques and Clinical Applications , 2017, Theranostics.

[50]  K. Cusi,et al.  Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. , 2014, Journal of hepatology.

[51]  A. fong,et al.  Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[52]  Vandana Khungar,et al.  Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis , 2016, Journal of clinical ultrasound : JCU.

[53]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[54]  G. Czarnota Role of ultrasound in the detection of apoptosis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[55]  Hsiang-Yang Ma,et al.  Effects of fatty infiltration in human livers on the backscattered statistics of ultrasound imaging , 2015, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[56]  Yin-Yin Liao,et al.  Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome , 2018, Entropy.

[57]  T. Berg,et al.  Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy , 2014, PloS one.

[58]  D. S̆timac,et al.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? , 2016, World journal of gastroenterology.

[59]  Minh Do,et al.  In-vivo study of quantitative ultrasound parameters in fatty rabbit livers , 2012, 2017 IEEE International Ultrasonics Symposium (IUS).

[60]  Lisa M Yerian,et al.  In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.

[61]  Li Ying,et al.  Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy , 2014, Journal of gastroenterology and hepatology.

[62]  S. W. Smith,et al.  Phase aberration correction in medical ultrasound using speckle brightness as a quality factor. , 1989, The Journal of the Acoustical Society of America.

[63]  Ching-Hua Chou,et al.  Sound speed correction in ultrasound imaging. , 2006, Ultrasonics.

[64]  B. Choi,et al.  Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. , 2014, Radiology.

[65]  Takamichi Murakami,et al.  Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation. , 2017, Radiology.

[66]  Michael C. Kolios,et al.  Quantitative ultrasound characterization of cancer radiotherapy effects in vitro. , 2008, International journal of radiation oncology, biology, physics.

[67]  Minh N. Do,et al.  Spectral-based quantitative ultrasound imaging: A model free approach , 2018 .

[68]  R. Torella,et al.  The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[69]  C. Kuni,et al.  Correlation of Fourier spectral shift‐determined hepatic acoustic attenuation coefficients with liver biopsy findings. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[70]  Brian W. Anthony,et al.  Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. , 2018, Ultrasound in medicine & biology.

[71]  Rita J. Miller,et al.  Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound. , 2019, Ultrasound in medicine & biology.

[72]  Xiaoping Hu,et al.  Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique. , 2009, Radiology.

[73]  J. Zagzebski,et al.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy. , 2017, AJR. American journal of roentgenology.

[74]  W. O’Brien,et al.  Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease , 2018, European Radiology.

[75]  V. Wong,et al.  Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease , 2016, Journal of gastroenterology and hepatology.

[76]  D. Rubens,et al.  Shear wave dispersion measures liver steatosis. , 2012, Ultrasound in medicine & biology.

[77]  V. de Lédinghen,et al.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.

[78]  Meng-Su Zeng,et al.  Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.

[79]  J. Jang,et al.  Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease , 2016, PloS one.

[80]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[81]  M. Tanter,et al.  Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. , 2015, Journal of hepatology.

[82]  D. H. Lee,et al.  Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification , 2017, Clinical and molecular hepatology.

[83]  E. Feleppa,et al.  Relationship of Ultrasonic Spectral Parameters to Features of Tissue Microstructure , 1987, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[84]  Eliseo Guallar,et al.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.

[85]  L. Wilson,et al.  Measurement of velocity of propagation from ultrasonic pulse-echo data. , 1982, Ultrasound in medicine & biology.

[86]  K. Cusi,et al.  The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease , 2015, Hepatology.

[87]  D E Robinson,et al.  Clinical Sound Speed Measurement in Liver and Spleen in Vivo , 1987, Ultrasonic imaging.

[88]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.

[89]  Claude B Sirlin,et al.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. , 2018, The British journal of radiology.

[90]  L. Castéra,et al.  Non-invasive diagnosis of hepatic steatosis , 2016, Hepatology International.

[91]  Michael C. Kolios,et al.  Ultrasonic spectral parameter characterization of apoptosis. , 2002, Ultrasound in medicine & biology.

[92]  Laurent Castera,et al.  Non-invasive evaluation of liver fibrosis using transient elastography. , 2008, Journal of hepatology.

[93]  L. Sandrin,et al.  Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. , 2016, Ultrasound in medicine & biology.

[94]  Ernest J. Feleppa,et al.  Ultrasonic spectrum analysis for tissue evaluation , 2003, Pattern Recognit. Lett..

[95]  C. Sirlin,et al.  Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis , 2018, Hepatology.

[96]  S. Horgan,et al.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.

[97]  Zamir Halpern,et al.  Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. , 2009, AJR. American journal of roentgenology.

[98]  F. Tacke,et al.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.

[99]  J. Stoker,et al.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.

[100]  K. Nightingale,et al.  Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging , 2015, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.

[101]  Manuel Romero-Gómez,et al.  miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. , 2018, Journal of hepatology.

[102]  Osamu Maenishi,et al.  Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation. , 2017, Radiology.

[103]  Rohit Loomba,et al.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. , 2017, AJR. American journal of roentgenology.

[104]  L. X. Yao,et al.  Backscatter Coefficient Measurements Using a Reference Phantom to Extract Depth-Dependent Instrumentation Factors , 1990, Ultrasonic imaging.

[105]  P. Mohana Shankar,et al.  A general statistical model for ultrasonic backscattering from tissues , 2000, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[106]  Ming-de Lu,et al.  Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound , 2016, European Radiology.

[107]  Jonathan Mamou,et al.  Review of Quantitative Ultrasound: Envelope Statistics and Backscatter Coefficient Imaging and Contributions to Diagnostic Ultrasound , 2016, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.

[108]  Jae Young Lee,et al.  Hepatic Steatosis: Assessment with Acoustic Structure Quantification of US Imaging. , 2016, Radiology.

[109]  G. Chartrand,et al.  MRI‐determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes , 2016, Journal of magnetic resonance imaging : JMRI.

[110]  J A Zagzebski,et al.  Ultrasound backscatter and attenuation in human liver with diffuse disease. , 1999, Ultrasound in medicine & biology.

[111]  H. Busse,et al.  Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. , 2015, World journal of gastroenterology.

[112]  V. Wong,et al.  Can the same controlled attenuation parameter cut‐offs be used for M and XL probes for diagnosing hepatic steatosis? , 2018, Journal of gastroenterology and hepatology.

[113]  J A Zagzebski,et al.  Quantitative Ultrasound Imaging: in Vivo Results in Normal Liver , 1993, Ultrasonic imaging (Print).

[114]  C. Riely,et al.  Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. , 1986, Radiology.

[115]  B. Neuschwander‐Tetri,et al.  Vibration‐Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[116]  Anthony Gamst,et al.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.